Effect of Dietary Habits on Metabolic Health

November 2, 2020 updated by: Frank AJL Scheer, PhD, Brigham and Women's Hospital
The goal of this application is to understand the connection between people's eating habits and the risk for developing diabetes, obesity, and cardiovascular disease.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

More than a third of U.S. adults are obese (BMI greater than 30), 8-12% of adults suffer from type 2 diabetes, and up to 30% of adults have pre-diabetes. Recent research studies have suggested that it is not just what we eat, but also when we eat that may put us at risk for obesity and type 2 diabetes. Skipping breakfast and eating late at night have been associated with an increased risk for obesity and type 2 diabetes (T2D), substantiated by recent animal and human experimental studies showing that altered meal timing itself, without changes in caloric intake, can influence weight regulation and impaired glucose tolerance. This research will determine in prediabetic and non-diabetic participants whether delaying meal times worsens glucose tolerance, leads to physiological changes favoring a positive energy balance, and increases caloric intake. This research will provide mechanistic insights into the metabolic consequences of changing meal timing and may help in evidence-based approaches to improve dietary interventions in the fight against obesity and T2D.

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • Brigham and Women's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • BMI between 25 and 37.9 kgm-2
  • Adults with regular sleep-wake timing
  • Non-smokers
  • Completion of medical and psychological screening tests
  • Able to spend 14 consecutive days in the sleep laboratory

Exclusion Criteria:

  • BMI < 25 or > 37.9 kgm-2
  • History of neurological or psychiatric disorder
  • History of sleep disorder or regular use of sleep-promoting medication
  • Current prescription, herbal, or over-the-counter medication use
  • Traveling across 2 or more time zones within past 3 months
  • Donating blood within past 8 weeks
  • Worked night or rotating shift work within past 3 years
  • Hearing impairment
  • Drug or alcohol dependency

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Early Meals
Meals are eaten early in the wake episode
Experimental: Late Meals
Meals are eaten late in the wake episode

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in plasma leptin levels across sleep/wake cycle
Time Frame: During standardized meals scheduled on Days 3 and 6
Frequent blood samples
During standardized meals scheduled on Days 3 and 6
Change in circadian profile of plasma leptin
Time Frame: During constant routine (Days 7-8)
Frequent blood samples
During constant routine (Days 7-8)
Change in glucose tolerance
Time Frame: During standardized meals scheduled on Days 3 and 6
Frequent blood samples
During standardized meals scheduled on Days 3 and 6
Change in circadian profile of plasma glucose levels
Time Frame: During constant routine (Days 7-8)
Frequent blood samples
During constant routine (Days 7-8)
Change in plasma insulin levels after standardized test meal
Time Frame: During standardized meals scheduled on Days 3 and 6
Frequent blood samples
During standardized meals scheduled on Days 3 and 6
Change in circadian profile of plasma insulin levels
Time Frame: During constant routine (Days 7-8)
Frequent blood samples
During constant routine (Days 7-8)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in circadian phase markers, such as from core body temperature, melatonin, cortisol
Time Frame: During constant routine (Days 7-8)
Core temperature and frequent blood samples
During constant routine (Days 7-8)
Changes circadian rhythm in resting energy expenditure
Time Frame: During constant routine (Days 7-8)
Indirect calorimetry
During constant routine (Days 7-8)
Change in hunger and appetite, mood, and cognitive performance
Time Frame: Tests taken throughout the protocol, Days 1-9
Subjective ratings and cognitive tests performed via computer interface
Tests taken throughout the protocol, Days 1-9
Changes in microbiota, gene expression, epigenetic or proteomic markers
Time Frame: Throughout the protocol during Days 3 and 6, and during constant routine (Days 7-8)
Frequent blood samples and saliva samples
Throughout the protocol during Days 3 and 6, and during constant routine (Days 7-8)
Changes in sleep
Time Frame: Sleep will be measured during the night after Days 2 and 5
Polysomnography
Sleep will be measured during the night after Days 2 and 5
Change in insulin sensitivity, gene expression, epigenetic, lipidomic or proteomic markers from isolated adipocytes
Time Frame: On Day 5 of each protocol
2 fat biopsies, one sample will be taken during each protocol
On Day 5 of each protocol

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Frank AJL Scheer, PhD, Brigham and Women's Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2014

Primary Completion (Actual)

April 21, 2019

Study Completion (Actual)

April 21, 2019

Study Registration Dates

First Submitted

November 20, 2014

First Submitted That Met QC Criteria

November 20, 2014

First Posted (Estimate)

November 24, 2014

Study Record Updates

Last Update Posted (Actual)

November 4, 2020

Last Update Submitted That Met QC Criteria

November 2, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • R01DK099512 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Meal schedule

3
Subscribe